Patents by Inventor Klaus Flechsenhar

Klaus Flechsenhar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-(2-methylamino-pyrimidin-4-yl)-1h-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated to osteoarthritis
    Patent number: 9968605
    Abstract: 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated with osteoarthritis in the knee.
    Type: Grant
    Filed: June 30, 2015
    Date of Patent: May 15, 2018
    Assignee: Sanofi
    Inventors: Tobias Paehler, Klaus Flechsenhar, Kirsten Grothe, Martin Lunnon, Christelle Jan
  • 2-(2-METHYLAMINO-PYRIMIDIN-4-YL)-IH-INDOLE-5-CARBOXYLIC ACID [(S)-1-CARBAMOYL-2-(PHENYL-PYRIMIDIN-2-YL-AMINO)-ETHYL]-AMIDE FOR USE IN THE TREATMENT OF PAIN ASSOCIATED TO OSTEOARTHRITIS
    Publication number: 20170119765
    Abstract: 2-(2-methylamino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid [(S)-1-carbamoyl-2-(phenyl-pyrimidin-2-yl-amino)-ethyl]-amide for use in the treatment of pain associated with osteoarthritis in the knee.
    Type: Application
    Filed: June 30, 2015
    Publication date: May 4, 2017
    Inventors: Tobias Paehler, Klaus Flechsenhar, Kirsten Grothe, Martin Lunnon, Christelle Jan
  • Vascular stent
    Patent number: 8133269
    Abstract: In order to provide a vascular stent, with which the risk of restenosis is reduced without having to use anti-proliferative active substances, there is proposed a carrier of a dimensionally stable material, as well as one or more layers, which are disposed at least in sections on the carrier, of a material based on crosslinked gelatin that is resorbable under physiological conditions, wherein the adhesion between the carrier and the layer and/or between individual layers can be neutralised.
    Type: Grant
    Filed: November 11, 2009
    Date of Patent: March 13, 2012
    Assignee: Gelita AG
    Inventors: Klaus Flechsenhar, Michael Ahlers
  • RAPIDLY WETTING MATERIAL CONTAINING HYDROCOLLOID, METHOD FOR THE MANUFACTURE THEREOF AND USE THEREOF
    Publication number: 20110071227
    Abstract: The present invention relates to a method for the production of a quickly wettable material containing natural hydrocolloid in the form of a shaped body, in which a material containing natural hydrocolloid in the form of a shaped body is exposed to a plasma.
    Type: Application
    Filed: October 4, 2010
    Publication date: March 24, 2011
    Applicant: GELITA AG
    Inventors: Michael Ahlers, Steffen Oesser, Michael Grzinia, Klaus Flechsenhar
  • VASCULAR STENT
    Publication number: 20100057200
    Abstract: In order to provide a vascular stent, with which the risk of restenosis is reduced without having to use anti-proliferative active substances, there is proposed a carrier of a dimensionally stable material, as well as one or more layers, which are disposed at least in sections on the carrier, of a material based on crosslinked gelatin that is resorbable under physiological conditions, wherein the adhesion between the carrier and the layer and/or between individual layers can be neutralised.
    Type: Application
    Filed: November 11, 2009
    Publication date: March 4, 2010
    Applicant: GELITA AG
    Inventors: Klaus Flechsenhar, Michael Ahlers